Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by prophetoffactzon Jul 29, 2022 5:36am
98 Views
Post# 34859224

RE:RE:RE:Zacks update and target price

RE:RE:RE:Zacks update and target price
 
FUNDSTRAT: “.. disinflation tailwinds strengthening .. we think this is turning out to the be an August 1982 moment,” when stocks “recovered the entire 36 month bear market loss in 4 months .. that is why we think S&P 500 could be >4,800 before year-end ..” -

<< Previous
Bullboard Posts
Next >>